Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/IIa Study of GC3106 Quadrivalent Cell-Culture Based Influenza Vaccine in Healthy Subjects
KCT0001261Phase 2Completed
- Sponsor
- Ministry of Health & Welfare
- Start
- Oct 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GC3106 in influenza, sponsored by Ministry of Health & Welfare. Started Oct 2014; status: completed.
02
Drugs
GC3106
03
Conditions
influenza
Beyond the preview
Go deeper on KCT0001261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001261.